Net Income (Quarterly) Chart

Historical Net Income (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 -3.835M
March 31, 2026 -2.692M
December 31, 2025 -2.688M
September 30, 2025 -4.106M
June 30, 2025 -2.200M
March 31, 2025 -3.476M
December 31, 2024 -2.383M
September 30, 2024 -2.229M
June 30, 2024 -1.710M
March 31, 2024 -2.146M
December 31, 2023 -1.702M
September 30, 2023 -2.087M
June 30, 2023 -1.873M
March 31, 2023 -2.184M
December 31, 2022 -3.479M
September 30, 2022 -2.644M
June 30, 2022 -2.678M
March 31, 2022 -2.572M
Date Value
December 31, 2021 -3.480M
September 30, 2021 -3.296M
June 30, 2021 -3.276M
March 31, 2021 -4.262M
December 31, 2020 -0.7568M
September 30, 2020 -2.117M
June 30, 2020 -2.498M
March 31, 2020 -1.827M
December 31, 2019 -3.912M
September 30, 2019 -1.696M
June 30, 2019 -1.268M
March 31, 2019 -0.8294M
December 31, 2018 -0.5843M
September 30, 2018 -0.6202M
March 31, 2018 -0.5275M
December 31, 2017 -0.3181M
September 30, 2017 -0.3586M
June 30, 2017 -1.339M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (Quarterly) Range, Past 5 Years

View Net Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (Quarterly) Benchmarks

View Net Income (Quarterly) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 23.00M
Corcept Therapeutics, Inc. 42.14M
Veru, Inc. -6.988M
Johnson & Johnson 5.534B
Eli Lilly & Co. 7.095B

Net Income (Quarterly) Related Metrics